Insmed Incorporated ( INSM) - Stock Earnings
INSM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026, midnight | — / — | — | — / — | — |
INSM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -328.5 million USD | 263.8 million USD |
| 2026Q1 | -163.6 million USD | 306.0 million USD |
| 2026Q2 | -13.2 million USD | 425.5 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
INSM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -749.6 million USD | 305.2 million USD |
| 2024 | -913.8 million USD | 363.7 million USD |
| 2025 | -1.3 billion USD | 606.4 million USD |
| 2026 Est. | — | — |
INSM
Price: $100.60
52 week price:
Earnings Per Share: -4.12 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.3 million
Ebitda: -42.9 millionMarket Capitalization: 22.8 billion